窄带成像与白光及定位活检对胃黏膜肠上皮化生的检出比较:一项前瞻性盲法试验
该前瞻性盲法试验纳入112例上消化道内镜检查患者,比较高清白光内镜、窄带成像(NBI)和定位活检对胃黏膜肠上皮化生(GIM)的检出率。NBI和定位活检检出GIM的患者比例分别为65%和76%,均高于高清白光的29%(P均<.005)。结论认为高清白光内镜不足以检出高危患者的GIM,应采用NBI靶向活检联合定位活检。
要点
- NBI检出GIM患者比例22/34(65%),定位活检26/34(76%),均高于高清白光10/34(29%)(P均<.005)。
- 仅NBI检出GIM者6例,仅定位活检检出者10例,无患者仅由高清白光检出GIM。
- NBI和定位活检检出GIM位点比例分别为30/57(53%)和38/57(67%),高于高清白光16/57(28%)(P均<.005)。
核心结论
- 高清白光内镜不足以检出胃癌风险增高患者的胃黏膜肠上皮化生。
- 应采用NBI靶向活检联合定位活检。
研究设计与样本
- 前瞻性盲法试验,纳入112例接受上消化道内镜检查的患者。
- 患者先由一名内镜医师行高清白光检查,再由另一名对白光结果不知情的内镜医师行NBI检查。
- NBI后对异常区域行靶向活检,随后每例患者行5处定位活检。
- 活检标本由对采集方式不知情的病理医师判读。
主要发现
- 112例患者中107例(96%)为西班牙裔或亚裔,34例(30%)检出GIM。
- NBI检出GIM患者22/34(65%),定位活检26/34(76%),高清白光10/34(29%)(P均<.005)。
- 仅NBI检出GIM者6例,仅定位活检检出者10例,无患者仅由高清白光检出GIM。
- NBI检出GIM位点30/57(53%),定位活检38/57(67%),高清白光16/57(28%)(P均<.005)。
- 每例患者活检中位数:定位活检5处,NBI 2处,高清白光1处。
临床怎么用
- 作者认为高清白光内镜不足以检出胃癌风险增高患者的GIM。
- 作者建议采用NBI靶向活检联合定位活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Gastric intestinal metaplasia (GIM) is a gastric cancer precursor. Narrow-band imaging (NBI) may improve detection of GIM. We compared detection of GIM with high-definition white-light (HD-WL) endoscopy, NBI, and mapping biopsies in a population with increased gastric cancer risk. METHODS: Patients undergoing upper endoscopy had HD-WL examination by 1 endoscopist, followed by an NBI examination by a second endoscopist blinded to HD-WL findings. The location of abnormalities detected by HD-WL and NBI were recorded by a research coordinator, and targeted biopsies of abnormal areas were performed after NBI. Subsequently, 5 mapping biopsies were performed per patient. Biopsy specimens were read by a pathologist blinded to mode of acquisition. The primary outcome was the proportion of patients with GIM. RESULTS: We enrolled 112 patients: 107 (96%) were Hispanic or Asian, and 34 (30%) had GIM. Higher proportions of patients with GIM were detected by NBI (22/34 [65%]) and mapping (26/34 [76%]) versus HD-WL (10/34 [29%]) (P < .005 for both comparisons). GIM was detected by NBI in only 6 patients and only by mapping biopsy in 10 patients; no patient had GIM detected solely by HD-WL. Higher proportions of sites with GIM also were detected with NBI (30/57 [53%]) and mapping biopsies (38/57 [67%]) than HD-WL (16/57 [28%]) (P < .005 for both comparisons). The median number of biopsies per patient with mapping biopsies (5) was significantly higher than with NBI (2) or HD-WL (1). CONCLUSIONS: HD-WL endoscopy is insufficient for detection of GIM in patients at increased risk for gastric cancer. NBI-targeted biopsies plus mapping biopsies should be used. (Clinical trial registration number: NCT02197351.).
引用
- Buxbaum JL, Hormozdi D, Dinis-Ribeiro M, et al. Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc. 2017. PMID: 28366441. doi:10.1016/j.gie.2017.03.1528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。